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Abstract
Background: Discussing deceased organ donation can be difficult not only for families but for health professionals
who initiate and manage the conversations. It is well recognised that the methods of communication and
communication skills of health professionals are key influences on decisions made by families regarding organ donation.
Methods: This multicentre study is being performed in nine intensive care units with follow-up conducted by the Organ
and Tissue Donation Service in New South Wales (NSW) Australia. The control condition is pre-intervention usual practice
for at least six months before each site implements the intervention. The COMFORT intervention consists of six elements:
family conversations regarding offers for organ donation to be led by a “designated requester”; family offers for donation
are deferred to the designated requester; the offer of donation is separated from the end-of-life discussion that death is
inevitable; it takes place within a structured family donation conversation using a “balanced” approach. Designated
requesters may be intensivists, critical care nurses or social workers prepared by attending the three-day national “Family
Donation Conversation” workshops, and the half-day NSW Simulation Program. The design is pre-post intervention to
compare rates of family consent for organ donation six months before and under the intervention. Each ICU crosses from
using the control to intervention condition after the site initiation visit. The primary endpoint is the consent rate for
deceased organ donation calculated from 140 eligible next of kin families. Secondary endpoints are health professionals’
adherence rates to core elements of the intervention; identification of predictors of family donation decision; and the
proportion of families who regret their final donation decision at 90 days.
Discussion: The pragmatic design of this study may identify ‘what works’ in usual clinical settings when requesting organ
donation in critical care areas, both in terms of changes in practice healthcare professionals are willing and able to adopt,
and the effect this may have on desired outcomes. The findings of this study will be indicative of the potential benefits of
the intervention and be relevant and transferrable to clinical settings in other states and countries.
Trial registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12613000815763 (24 July 2013).
ClinicalTrials.gov: NCT01922310 (14 August 2013) (retrospectively registered).
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Background
Organ and tissue transplantation is the definitive treat-
ment for people with a wide range of end-stage organ
failures. Escalating worldwide demand continues to drive
efforts in many countries to increase the rate of de-
ceased organ donation [1]. In Australia in 2011 the an-
nual rate of deceased organ donation (15.1 donors per
million population, dpmp) was below similar countries
in the developed world such as the United Kingdom
(UK) (17 dpmp), and international leaders such as the
United States of America (USA, 25.9 dpmp), and Spain
(35.9 dpmp) [2].
In New South Wales (NSW), Australia, consent for
organ donation must be provided either from the patient
while living or, when incapacitated, from the senior
available next-of-kin (SaNOK): that is, a relative identi-
fied in line with an agreed family hierarchy [3]. In NSW
the annual consent rate increased from 51% in 2011 [4]
to 62% in 2013 [unpublished 2014 NSW Organ and Tis-
sue Donation Service (OTDS) data], contributing to an
annual national increase from 57% [5] to 61% [6] re-
spectively. Other countries with similar health systems
such as the UK, also reported a national consent rate of
around 60% for 2013/14 [7]. Yet this consent rate is
comparatively low in contrast to overwhelming positive
public opinion in surveys of the UK and Australian pop-
ulations with 90% and 69% respectively supporting do-
nation and willing to become organ donors, describing
predominantly altruistic beliefs on the topic [7–9]. Fur-
thermore the consent rate decreased to 29% [unpub-
lished 2011 NSW OTDS data] when families have been
offered organ donation at the hospital and the patient
had not previously registered their donation decision.
Physicians need effective communication skills when
approaching families regarding end-of-life decisions,
and skill enhancement has been advocated to maximise
the consent rate for deceased donation [10, 11]. The
difficulty of raising the subject of organ donation has
long been recognised. North American research re-
vealed Intensive Care Unit (ICU) physicians were
poorly prepared to understand grief reactions, missed
opportunities to provide emotional support, and failed
to listen to families and support informed decision-
making [12–14]. In Australia, a one-day donor aware-
ness program designed to increase health professional’s
understanding of organ donation and to provide skills
to sensitively conduct family donation conversations
has been available since 1994 [15], with intensivists
reporting this training as adequate preparation [16].
Despite that training, ICU nurses, intensivists and spe-
cialist donation nurses may avoid raising the topic due
to their own perceptions of a family’s grief, fear or guilt,
or of adding to a family’s distress [17, 18]. However, a
longitudinal study of 49 relatives in the UK reported
that discussing organ donation did not increase fam-
ilies’ distress [19].
The approach and skill of the health professional
making the donation request has been shown to be a
key influence on families’ donation decisions [20]. In
countries that lead in this field such as Spain and the
USA, health professionals working as transplant coordi-
nators or organ procurement coordinators receive spe-
cialised communication training and make the initial
approach to families [10, 21, 22]. In Australia, the man-
aging intensivist traditionally leads donation discussions
with introduction to the donation specialist nurse
(DSN) subsequent to verbal agreement to organ dona-
tion. DSNs are trained in organ donation activities, but
not necessarily in leading the conversation [23]. Many
intensivists only participate in organ donation discussions a
few times per year, providing limited opportunities to prac-
tice the necessary specialised communication skills [16].
‘Best practice’ family approach
Intensive care medicine professional organisations and
health authorities in Australia and the UK provide prac-
tice guidelines for communication between families and
health professionals during end-of-life care, including
organ donation decisions [23, 24]. In Spain and the UK
a ‘family approach’ has been recommended with the
requesting conversation planned between the managing
team and a Specialist Nurse-Organ Donation [10, 25].
Ensuring families understand that the patient has died
or that death is inevitable before donation is raised is a
key feature. The initial approach to the topic of donation
has been identified as a pivotal point in the process be-
cause families often make their donation decision at that
time [26].
Effective communication within a structured multidis-
ciplinary family meeting, also termed ‘family conference’,
has been recommended for ICU physicians to facilitate
informed decision making based on the anticipated
wishes of the patient rather than those of the patient’s
relatives [27–31]. Meetings ideally require multidiscip-
linary team planning, a private location and effective
communication techniques such as the use of everyday
language, listening and acknowledging relatives’ emo-
tions or opinions and demonstrating compassion ver-
bally and through non-verbal techniques [23, 32]. In the
USA communication approaches have moved from a
“neutral” position towards organ donation towards one
of “dual advocacy”. This entails use of positive language,
equally presenting the needs of the donor family and
people on transplant waiting lists, assuming that most
people would want to help others by donation [33, 34].
Training organ procurement coordinators (n = 22) in ef-
fective communication techniques for requesting organ
donation increased the consent rate in participating
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hospitals by 9.2%, over 2 years [22, 35]. Families who
were certain of their organ donation decision reported
that health professionals providing them with clear in-
formation and emotional support were key factors in
helping them make decisions with which they remained
comfortable over time [36].
Studies conducted in North America have shown some
donation decisions were later regretted, and that this oc-
curred more frequently when the decision was to decline
donation. For example, of 285 relatives interviewed an
average of 13 ± 9 days after death, only 4% (6/147) who
had agreed to donation would later have preferred they
had declined. By contrast, of those who declined dona-
tion, 27% (37/138) later wished they had agreed [37].
Decisional regret, where relatives either regretted their
decision or were unsure they would make the same deci-
sion again, persisted up to 10 months after bereavement.
A study of 199 relatives interviewed eight to ten months
after death revealed decisional regret was more evident
in those who declined (42%; 19/45) than agreed to do-
nation (9%; 15/154) [36]. Decisional regret was more
likely when organ donation was raised before relatives
were informed of the patient’s death, and when the first
approach was by a health professional who managed
the patient’s care, before a formal request from a separ-
ate organ procurement team [37].
Specialised communication training
In Australia, training in specialised communication for
health professionals who offer donation has been a key
component of a national reform agenda [38]. A national
program of specialised training in family-centred com-
munication regarding organ donation, developed in col-
laboration with the Gift of Life Institute (Philadelphia,
USA), was introduced in October 2011 [39]. The revised
program delivered in two modules over three days, in-
corporated face-to-face presentations of theory followed
by practical training with role-play exercises [40]. This
approach — the Organ and Tissue Authority (OTA)
Family Donation Conversation (FDC) core and practical
modules – (see Additional file 1) has been adopted as
‘best practice’; intensive care specialists and organ dona-
tion health professionals elect to attend, and the College
of Intensive Care Medicine made completion of the core
module a mandatory training requirement for intensive
care trainees from 2014 [41]. However, role-play alone
may not adequately replicate the emotional nature of do-
nation conversations.
In NSW, training for health professionals selected as
“designated requesters” to lead donation conversations
has been supplemented by a simulation program [4].
Piloted in 2012 the program uses real donation scenarios
with standardised relatives played by professional actors
[42]. Health professionals are able to rehearse, review
and reflect on their developing effective communication
skills when offering donation in a protected learning
environment, and thereby become more comfortable
discussing these topics. These ‘best practice’ methods
involving use of specialised requesters to lead deceased
organ donation discussions with families are based on
work from other countries adapted to but not formally
tested in Australian conditions. This study will examine
implementation of a ‘best practice’ family approach
intervention and identify its effectiveness in terms of




The aim of this study is to examine the process of organ
donation decision-making, and to test whether changes
in requesting practices change rates of family consent
for organ donation and other family-based outcomes. A
secondary aim is to examine whether changes in
requesting practices result in increased satisfaction by
families with their donation decision. The hypothesis for
the trial component is that, compared to current usual
practice, a ‘best practice’ family approach intervention
will increase the family consent rate for deceased organ
donation.
Design
This is a pre-post intervention design where rates of
consent for organ donation for at least six months be-
fore implementation of the program in each ICU will be
compared to the rates of consent for organ donation
under the intervention.
Settings
The study will be conducted in the ICUs or locations
such as Emergency Departments when the patient is
managed by ICU health professionals, of nine metro-
politan and rural hospitals in NSW, with follow-up
conducted by the NSW OTDS.
The COMmunication with families regarding ORgan and
tissue donation after death in intensive care (COMFORT)
intervention
The intervention is a modification of current standard
practice procedures for offering donation to families of
potential organ donors. There are six essential ‘best
practice’ elements of the intervention:
1. A designated requester has primary responsibility for
discussions regarding organ donation with the family
of a potential donor. Primary communication with
families regarding end of life management and death
remains the responsibility of the managing team.
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2. Designated requesters are volunteer intensivists,
experienced critical care nurses, or social workers
who have been deemed appropriate by the site
principal investigator/ICU department head to
undertake the role, and complete mandatory
training (see Additional file 1). Up to six designated
requesters are estimated to be required at each
study hospital.
3. The offer of donation is separated from the
conversation where families are informed of the
patient’s death. It is important the family have
accepted the inevitability of death before donation
is raised [25].
4. If families raise the topic of organ or tissue donation,
the managing health professional sensitively defers the
first donation conversation to the designated requester.
5. Donation conversations are conducted within the
structure of a family meeting, based on evidence-
based guidelines for high quality communication
regarding end-of-life care [23, 28–30].
6. The requester uses a ‘balanced approach’:
information is provided in a proactive manner,
using open-ended questions to encourage active
participation of family members in discussion.
Information is provided about the benefits of organ
and tissue donation for both families and recipients [39].
Key features to which the multidisciplinary team and
designated requesters are expected to adhere are set out
in Table 1.
The training provides designated requesters preparation
and opportunities to practice elements three to six of the
COMFORT intervention. Designated requester training
requirements are completed subsequent to attending the
Organ and Tissue Authority FDC core and practical mod-
ules and the NSW simulation workshop (see Additional
file 1) [40, 42]. Subsequent attendance at the simulation
workshop is required for annual refresher training for
DSNs and social workers, and 18 monthly for intensivists,
for the duration of the COMFORT study.
As the study intervention is a modification to health
service delivery, it is led in each hospital by local special-
ist donation nurses and doctors. Education sessions are
delivered as required to colleagues in the departments of
emergency medicine, intensive care, neurosurgery and
social work to support and provide information and
feedback on the implementation process of the new
intervention. Information is collected from and on the
health professionals involved in each organ donation
event to track intervention fidelity.
Participants
Participants in this study are the families of patients who
are potential deceased organ and tissue donors and the
health professionals involved in each organ donation
event. Members of the managing team identify a possible
deceased organ donor who is apparently medically suit-
able for organ donation, and notify the donation special-
ist at the hospital or the OTDS. To be eligible for the
study a donation event must meet all inclusion and no
exclusion criteria as detailed below:
Inclusion criteria
Donation events identified by patients of all ages man-
aged in the ICU or under the care of ICU health profes-
sionals, who are potential deceased organ and tissue
donors. For the primary endpoint only, patients must
not have registered their donation wishes.
Exclusion criteria
Donation events or patients who fulfil one or more of
the following criteria:
a) A patient who is not medically suitable for deceased
organ and tissue donation;
b) A patient who does not have a SaNOK to participate
in donation conversations;
c) An adult patient in the ICU who is able to provide
first person consent for deceased donation, for
example a patient with cervical spine injury;
d) A patient who is suitable to donate only tissue after
death.
Endpoints
The primary endpoint for the study is the family consent
rate for deceased organ donation where the potential
donor had not previously registered their donation wishes.
Secondary endpoints are: health professionals’ adher-
ence rates to core elements of the COMFORT interven-
tion; identification of predictors of family donation
decision; and the proportion of SaNOK who report they
regretted their final donation decision at around 90 days
after enrolment.
Study outline
In line with usual practice, potential donors are identi-
fied, a registry check is performed to find any recorded
preference regarding organ donation by the patient, and
the process of assessing medical suitability is com-
menced (not necessarily in that order). In the COM-
FORT intervention condition the managing team is
responsible for delivering the news of death, and con-
tacts the donation specialist/designated requester to plan
the approach to the family and initiate the donation offer
(as above and Table 1). In the pre-intervention control
condition, the donation conversation is managed by the
healthcare professional(s) and processes are the usual
practice in that setting. A chart of the study design and
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data collection periods is shown in Fig. 1. The site initi-
ation visit is the point where hospitals crossover from
the control to the intervention condition. In both groups
families may take up to 72 h for a final donation
decision.
Bereavement support provided by the OTDS Family
Support Coordinator is offered to families who partici-
pated in the donation requesting conversation regardless
of their final organ donation decision. Senior next of kin,
or the delegated decision maker, who agrees to
Fig. 1 Chart of the study design and data collection periods. Shaded cells represent intervention periods; Blank cells represent control periods.
Each cell represents a data collection point, except those with ‘X’ N = NSW Organ and Tissue Donation Service, f = follow-up interviews
Table 1 Key adherence criteria for delivery of the ‘COMFORT’ intervention
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bereavement aftercare is invited to participate in the
subsequent follow-up interview at day 90 after
enrolment.
Evaluation: data collection and management
Setting
To characterise and describe the setting, data recorded
at the beginning and at completion of the study at each
site include: number of hospital and ICU beds; categor-
ies (medical/surgical/paediatric) of patients admitted to
the ICU; areas of specialty; medical, nursing and allied
health staffing establishments and ratios; availability of
private meeting rooms; frequency of multidisciplinary
communication (ward rounds; and family meetings).
Current control
To describe practice for the ‘control condition’ i.e. pre-
intervention details of donation events for the period of
six months before each site implements the intervention
and joins the program will be extracted retrospectively.
Data will include: eligibility for deceased organ donation;
patients’ date of birth, donation intent registered on
their motor vehicle licence and the Australian Organ
Donor Register; initiator of the donation conversation;
family final donation decision, and outcome of the dona-
tion event.
Intervention period screening
A screening log is maintained at the OTDS of notifica-
tion of patients who are apparently medically suitable
for deceased organ donation during the study interven-
tion period. DSNs routinely coordinate data collection at
each hospital and forward completed forms to the
OTDS for validation and consistency checks.
Donation events
A unique number is allocated to each potential organ
donor at enrolment. Data from eligible potential dona-
tion events include donation pathway (i.e. brain or cir-
culatory death), designation of initiator of the family
donation conversation, donation intent on a register,
and family donation decision. Also characteristics of
potential donors such as: date of birth, gender, ethni-
city, religion, primary event/cause of death, dates and
times of ICU admission and death, commencement of
retrieval surgery, and family contact details.
Family donation conversation
Adherence to elements of the family donation conversa-
tion is consecutively recorded on a case report form for
each donation event by self-report from the observations
of health professionals who participated in the meeting.
Details include general features of a structured family
meeting and specific topics discussed in the first
meeting. The role of the ICU health professional who
led the initial family donation conversation (termed the
‘requester’) is central to this process; their demographic,
training and number of donation requesting conversa-
tions experiences in the preceding calendar year are col-
lected by self report. Reporting is undertaken at the
closure of the conversation to minimise potential recall
bias. A consensus approach is used with equal weight
given to each health professional’s observations. Comple-
tion of the case report form may extend to one week.
The final donation decision by the family is recorded at
conclusion of the process. Reasons stated by the family
and/or perceived by the health professional for that deci-
sion at that time point will be noted. See Additional file 2
for the case report form.
Follow-up with the SaNOK
Follow-up bereavement aftercare will be offered to
SaNOK as part of the donation conversation process. An
invitation to participate in the follow-up interview and
the participant information sheet and consent form are
posted to SaNOK who agreed to follow-up approxi-
mately two weeks before the 90-day post bereavement
time point. Written or verbal consent are subsequently
sought from the SaNOK for the follow-up interview and
to audio-record it, although the interviewer will take
notes rather than audio-recording if participants prefer.
This contact procedure is similar to that used in previ-
ous research with families of potential organ donors
[43]. Hence the three-stage process for consent to
follow-up entails:
1. Initial verbal consent to the offer of bereavement
aftercare, followed by
2. Provision of written information and written or
verbal consent, and
3. Confirmation of consent before conducting the
interview, and for audio-recording.
The OTDS Family Support Coordinator conducts the
telephone interviews with senior next of kin who agree
to bereavement aftercare. Data sought include: demo-
graphic details; bereavement support received; informa-
tion received regarding organ and tissue donation, and
family members’ perception as to whether this was ad-
equate for them to make a decision; previous discussions
with their relative regarding organ and tissue donation;
if they would now make the same donation decision,
and their decision rationale.
Consent rates over time
To describe trends in family donation decisions over the
same time period as the COMFORT study and identify
any trends/changes over time notification data from all
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NSW hospitals ICUs and Emergency Departments are
collected. Data variables collected have been listed at
Donation events, above (with the addition of ethnicity,
religion, ICU stay and retrieval data as appropriate).
Statistical methods
The sample size calculation was performed using the
Simon’s two-stage design [44]. 140 eligible next of kin
families are required to be approached to provide con-
sent for organ donation. This will yield 80% power with
95% confidence to exclude a consent rate of 29% in
favour of a clinically worthwhile rate of 40% for the
intervention. An eligible next of kin family are those of
patients who had not registered their donation decision.
Additionally, in the first 46 eligible next of kin families
who are approached, if less than 15 have consented to
organ donation, consideration will be given to modifying
the study.
Statistical analysis
A patient flow-chart shows the number of patients eli-
gible and the numbers enrolled at each site. No imput-
ation is envisaged to be performed for next of kin where
the primary outcome is unknown. Summary statistics
will be presented for continuous variables, and counts
and percentages presented for categorical variables.
All analyses will apply the intention to treat
principle. For example in a case where the interven-
tion was not properly followed, such as the SaNOK
had organ donation raised by an inappropriate re-
quester instead of a designated requester, the patient
will still be included in the study and considered to
have received the intervention.
Paediatric cases defined as those aged less than or
equal to 16 years, will be analysed as a separate cohort.
To address the primary endpoint
 Consent rates provided by the next of kin for organ
and tissue donation where the potential donor had
not registered their decision will be calculated.
To address the secondary endpoints
1. Adherence to core elements of the intervention
will be obtained via the case report form and
rates calculated.
2. The proportion of all next of kin who report they
regretted their final decision either to consent or
to decline donation at 90 days will be calculated
with 95% Confidence Interval.
3. Characteristics of the donation process including
staff adherence to core elements of the intervention
and demographic characteristics of the potential
donor, senior next of kin and of the requester will
be explored. Exploratory analysis using both
univariate and multivariate regression methods
will be used as needed. A p-value of < 0.05 will be
considered statistically significant for retention in
the multivariate model and only univariate variables
with a p-value <0.20 will be considered for inclusion
to the multivariate model.
Categorical data (e.g. details of gender, religion, ethni-
city of patient and health care professional and reasons
to consent or decline donation) will be summarised by
frequencies and percentages. Continuous data (e.g. age,
time in family meetings) will be summarised using the
mean and standard deviation.
Additional analysis: consent rates over time
Consent rates for hospitals that have participated in the
“best practice” family approach intervention training will
be compared up to six months before the site initiation
visit with the consent rates under the intervention.
To establish the baseline (pre COMFORT) and con-
current data trends NSW state-wide, consent rates in
hospitals not participating in “best practice” family ap-
proach intervention training at any point during the
study will be presented over time.
The consent rates between NSW hospitals that had
ICU health professionals trained in the intervention and
NSW hospitals that never received the training will be
presented. This analysis will only include families that
were approached about organ donation before the hos-
pital introducing the intervention training.
Additional analysis: follow-up data
Summary statistics will be provided showing the next of
kin’s knowledge of their loved one’s organ donation
wishes.
Summary statistics of the next of kin’s demographic
data and their circumstances of the organ donation re-
quest will be presented by donation decision and by the
next of kin’s enduring (90 days) regret or support of
their donation decision.
Monitoring
The project manager will conduct a site initiation visit
and subsequent visits to each study site during the inter-
vention phase to support protocol compliance and ad-
herence to good clinical practice in research. Hospital
records, source documents and other study files will be
accessible at all study sites for monitoring and auditing
purposes. The OTDS will regularly monitor recruitment
by screening notifications of possible organ donors to
the organisation.
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Ethical considerations
The study is a pragmatic evaluation “in practice” of
adoption of key elements of the FDC training represent-
ing adherence to evidence-based guidelines for end-of-
life communication with families. As part of routine
care, health professionals delivering this intervention are
able to access existing psychological supervision for sup-
port should they wish.
It is possible that contacting families may cause them
anxiety or distress. This possibility is addressed by offer-
ing bereavement aftercare provided by the OTDS Family
Support Coordinator to families who declined organ do-
nation, currently not available to them under standard
care conditions, but routinely offered to families who
agreed to donation. In light of their existing relationship
with the family, their counselling expertise and inde-
pendence from the managing clinicians, the OTDS
Family Support Coordinator will conduct the Day-90
interview subsequent to family verbal or written con-
sent. Participants are able to change their mind at any
time without affecting eligibility for ongoing bereave-
ment support.
Discussion
This study has been designed to evaluate the uptake and
outcomes of a ‘best practice’ intervention entailing a
framework of evidence-based family conversations led by
a skilled ‘designated requester’ convened after the news of
a loved one’s death has been delivered, to make decisions
regarding end-of-life care and organ donation. This is an
important initiative to identify ‘what works’ in usual clin-
ical settings when requesting organ donation in critical
care environments, both in terms of what changes in prac-
tice healthcare professionals are willing and able to adopt,
and what effect this may have on desired outcomes.
A strength of this study is its pragmatic, ‘real world’
nature; findings will be immediately relevant and poten-
tially generalisable to other clinical settings as the study
is conducted as part of routine care. Standard care pro-
cedures of the ‘control’ condition will be detailed, enab-
ling other sites to make comparisons between their
practice and the practice employed in both ‘conditions’
of this study. Introduction of the designated requester
role to lead the initial family donation conversation will
be examined in both metropolitan and rural ICUs. Rea-
sons for health professionals’ decisions to deviate from
the intervention pathway will be collected prospectively,
to maximise understanding of the results of this study
and identify procedures to review or to incorporate in
future innovative implementation models.
Further strengths include characterisation of the do-
nation requesting process in such a way as to enable
identification of features of ‘best practice’ that are im-
portant both from Australian healthcare professionals’
and families’ perspectives, particularly in cases when
they were unaware of the donation preference of the
potential organ donor. Reasons for the families’ dona-
tion decisions are recorded contemporaneously, thereby
minimising the effect of recall bias. Use of an inter-
viewer independent of the hospital managing team for
family follow-up interviews is intended to facilitate
open disclosure of their experiences of events.
There are some limitations of this study. Firstly, there
were constraints on design. A pre-post intervention de-
sign was chosen in order to maximise recruitment and
obtain an adequate sample size within a reasonable time
period. Alternative designs were not feasible. For ex-
ample, a randomised controlled trial design would have
incurred high likelihood of contamination of ‘control’
sites by features of ‘best practice’ once national educa-
tion began to be delivered in NSW. Cluster randomised
control designs were discounted due to insufficient
numbers of hospitals in NSW. A stepped wedge design
was not possible as the crossover point for each site was
primarily dependent upon staff release for the designated
requester training, which in turn was dependent on local
staffing; consequently this could not be randomly allo-
cated. The pre-post design enabled all units to partici-
pate in the intervention and made economical use of
‘control’ data from every site.
Secondly, there are some potential threats to the val-
idity of study findings. The delivery of the national
FDC training may result in increased family consent
rates independent of the study intervention. However,
this training is only one part of the support planned for
core elements of this intervention, so, if effective, con-
sent rates would still be expected to increase more rap-
idly under the ‘intervention’ compared to the ‘control’
condition. We are unable to gauge the impact of
ongoing community education activities directed to in-
crease the proportion of people who register their do-
nation decision. Selection bias is acknowledged for the
follow-up interviews, in that those families who either
were not offered or do not wish to have bereavement
aftercare are excluded from this portion of the study.
Practical issues related to the delivery of a multi-
centre trial made a staged roll-out of implementation
necessary. However, operational issues, including the
turn-over of DSNs and the time required for the requis-
ite numbers of designated requesters to complete all
training workshops (up to a year), caused delay in re-
cruitment at some sites. The original plan for sequen-
tial start in equally spaced time periods could not
occur. Practical issues may also affect protocol adher-
ence; for example, without funding to allocate desig-
nated requesters to on-call rosters, availability is
dependent on usual rostering procedures. Implementa-
tion of the intervention is therefore pragmatic being
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dependent on factors that will equally affect any future
delivery as part of routine practice as well as a research
intervention.
Additional files
Additional file 1: Summary of training program. (DOCX 115 kb)
Additional file 2: COMFORT study case report forms 2–6. (PDF 264 kb)
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